AcuNetx, Inc. markets a broad range of diagnostic and therapeutic products for the medical care industry. The company is one of America’s leading suppliers of videonystagmography (VNG) systems; equipment which is used to test inner-ear and central motor functions in patients with dizzyness or balance disorders.
AcuNetx announced its acceptance of the resignation of president and CEO Ronald A. Waldorf. Mr. Waldorf cited personal responsibilities as a key factor in his decision to resign in a letter to the board: “It is with a heavy heart that I tender my resignation, but my family needs me and I cannot, in all good conscience, ignore those nearest me. Nevertheless, I can be counted on to provide ongoing guidance and counsel as a board member.”
Board chairman Robert S. Corrigan has been chosen as the company’s interim CEO, and offered his own comments on the situation: “I am enthusiastic and optimistic facing the challenge of building this company and am intent on growing sales, shoring up the balance sheet and strengthening our ties with the financial community.”
As of 2:45 p.m. ET AcuNetx stock was up more than 133 percent, rising to seven cents from this morning’s $0.03 open; this figure represents the company’s highest share price since April.
Let us hear your thoughts below: